The co-imaging of gamma camera measurements of aerosol deposition and respiratory anatomy

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 26, Issue 3, 2013, Pages 123-130

  Conway, Joy ^a,b   Fleming, John ^b   Bennett, Michael ^b   Havelock, Tom ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

aerosol deposition; CT; HRCT; lung imaging; respiratory anatomy; SPECT

Indexed keywords

KRYPTON;

AEROSOL; BRONCHOSCOPY; CALCULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMPUTED TOMOGRAPHY SCANNER; COMPUTER SIMULATION; CONFOCAL LASER MICROSCOPY; DISEASE COURSE; DOSIMETRY; EXTRACELLULAR MATRIX; GAMMA CAMERA; GAMMA SCINTIGRAPHY; HUMAN; IMAGE ANALYSIS; INHALATION; ISOTOPE LABELING; LUNG STRUCTURE; LUNG VENTILATION; MUCOCILIARY CLEARANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PARTICLE SIZE; RADIATION DOSE; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; TOMOGRAPHY;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; PHARMACEUTICAL PREPARATIONS; RADIONUCLIDE IMAGING; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878411688     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0960     Document Type: Review

References (58)

1. Newman S, and Fleming J: Challenges in assessing regional distribution of inhaled drug in the human lungs. Expert Opin Drug Deliv. 2011;8:841-855.
2. Dolovich M, and Labiris R: Imaging drug delivery and drug responses in the lung. Proc Am Thorac Soc. 2004;1:329-337.
3. Scheuch G, Bennett W, Borgström L, Clark A, Dalby R, Dolovich M, Fleming J, Gehr P, Gonda I, O'Callaghan C, Taylor G, and Newman S: Deposition, imaging, and clearance: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23 Suppl 2:S39-S57.
4. Carvalho TC, Peters JI, and Williams RO: Influence of particle size on regional lung deposition-what evidence is there? Int J Pharm. 2011;406:1-10.
5. Dolovich MB: 18F-Fluorodeoxyglucose positron emission tomographic imaging of pulmonary functions, pathology, and drug delivery. Proc Am Thorac Soc. 2009;6:477-485.
6. Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, and Finlay WH: In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. J Aerosol Med Pulm Drug Deliv. 2010;23 Suppl 2:S59-S69.
7. Finlay WH, and Martin AR: Recent advances in predictive understanding of respiratory tract deposition. J Aerosol Med Pulm Drug Deliv. 2008;21:189-206.
8. Rostami AA: Computational modeling of aerosol deposition in respiratory tract: a review. Inhal Toxicol. 2009;21:262-290.
9. Martonen TB, Smyth HD, Isaacs KK, and Burton RT: Issues in drug delivery: concepts and practice. Respir Care. 2005; 50:1228-1252.
10. Martonen TB, Schroeter JD, and Fleming JS: 3D in silico modeling of the human respiratory system for inhaled drug delivery and imaging analysis. J Pharm Sci. 2007;96:603-617.
11. Gutte H, Mortensen J, Jensen CV, von der Recke P, Petersen CL, Kristoffersen US, and Kjaer A: Comparison of V/Q SPECT and planar V/Q lung scintigraphy in diagnosing acute pulmonary embolism. Nucl Med Commun. 2010;31: 82-86.
12. Gutte H, Mortensen J, Jensen CV, Johnbeck CB, von der Recke P, Petersen CL, Kjaergaard J, Kristoffersen US, and Kjaer A: Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography. J Nucl Med. 2009;50:1987-1992.
13. Le Duc-Pennec A, Le Roux P-Y, Cornily J-C, Jaffrelot M, Delluc A, de Saint-Martin L, Guillo P, Le Gal G, Salaun PY, and Leroyer C: Diagnostic accuracy of single photo emission tomography ventilation perfusion (SPECT V/Q) lung scan in the diagnosis of pulmonary embolism. Chest. 2011;141: 381-387.
14. Corcoran TE, Thomas KM, Myerburg MM, Muthukrishnan A, Weber L, Frizzell R, and Pilewski JM: Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway. Eur Respir J. 2010;35:781-786.
15. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, and Boucher RC: Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354:241-250.
16. Bennett WD, Daviskas E, Hasani A, Mortensen J, Fleming J, and Scheuch G: Mucociliary and cough clearance as a biomarker for therapeutic development. J Aerosol Med Pulm Drug Deliv. 2010;23:261-272.
17. Daviskas E, Anderson SD, Eberl S, and Young IH: Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction. Respir Med. 2010;104:1645-1653.
18. Fleming J, Conway J, Majoral C, Tossici-Bolt L, Katz I, Caillibotte G, Perchet D, Pichelin M, Muellinger B, Martonen T, Kroneberg P, and Apiou-Sbirlea G: The use of combined single photon emission computed tomography and X-ray computed tomography to assess the fate of inhaled aerosol. J Aerosol Med Pulm Drug Deliv. 2011;24:49-60.
19. Fleming JS, Conway JH, Bolt L, and Holgate ST: A comparison of planar scintigraphy and SPECT measurement of total lung deposition of inhaled aerosol. J Aerosol Med. 2003;16:9-19.
20. Newman SP, Pitcairn GR, Hirst PH, and Rankin L: Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs. Adv Drug Deliv Rev. 2003;55:851-867.
21. Esposito-Festen JE, Zanen P, Tiddens HAWM, and Lammers JW: Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size. Br J Clin Pharmacol. 2007;64:328-334.
22. Laube BL, Benedict GW, and Dobs AS: Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus. J Aerosol Med. 1998;11:153-173.
23. Bergeron C, Hauber HP, Gotfried M, Newman K, Dhanda R, Servi RJ, Ludwig MS, and Hamid Q: Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol. 2005;116:983-989.
24. Usmani OS, Biddiscombe MF, and Barnes PJ: Regional lung deposition and bronchodilator response as a function of b2-agonist particle size. Am J Respir Crit Care Med. 2005;172: 1497-1504.
25. Biddiscombe MF, Meah SN, Underwood SR, and Usmani OS: Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition. J Aerosol Med Pulm Drug Deliv. 2011;24:165-173.
26. Weibel ER: Principles and methods for the morphometric study of the lung and other organs. Lab Invest. 1963;12: 131-155.
27. Fleming JS, Halson P, Conway J, Moore E, Nassim MA, Hashish AH, Bailey AG, Holgate ST, and Martonen TB: Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodality imaging. J Nucl Med. 1996;37:873-877.
28. Lindström M, Camner P, Falk R, Hjelte L, Philipson K, and Svartengren M: Long-term clearance from small airways in patients with cystic fibrosis. Eur Respir J. 2005;25:317-323.
29. Eberl S, Chan H-K, and Daviskas E: SPECT imaging for radioaerosol deposition and clearance studies. J Aerosol Med. 2006;19:8-20.
30. Pauwels R, Newman S, and Borgström L: Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. Eur Respir J. 1997;10:2127-2138.
31. Schroeter JD, Pritchard JN, Hwang D, and Martonen TB: Airway identification within planar gamma camera images using computer models of lung morphology. Pharm Res. 2005;22:1692-1699.
32. Fleming JS, Conway JH, Holgate ST, Moore EA, Hashish AH, Bailey AG, and Martonen TB: Evaluation of the accuracy and precision of lung aerosol deposition measurements from planar radionuclide imaging using simulation. Phys Med Biol. 1998;43:2423-2429.
33. Tossici-Bolt L, Fleming JS, Conway JH, and Martonen TB: An analytical technique to recover the third dimension in planar imaging of inhaled aerosols-(2) Estimation of the deposition per airway generation. J Aerosol Med. 2007;20:127-140.
34. Ilowite JS, Smaldone GC, Perry RJ, Bennett WD, and Foster WM: Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch Environ Health. 1989;44:267-273.
35. Regnis JA, Zeman KL, Noone PG, Knowles MR, and Bennett WD: Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia. Exp Lung Res. 2000;26:149-162.
36. Lindström M, Falk R, Hjelte L, Philipson K, and Svartengren M: Long-term clearance from small airways in subjects with ciliary dysfunction. Respir Res. 2006;7:79.
37. Donaldson SH, Corcoran TE, Laube BL, and Bennett WD: Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. Proc Am Thorac Soc. 2007;4:399-405.
38. Marthin JK, Mortensen J, Pressler T, and Nielsen KG: Pulmonary radioaerosol mucociliary clearance in diagnosis of primary ciliary dyskinesia. Chest. 2007;132:966-976.
39. Bennett WD, Herbst M, Alexis NE, Zeman KL, Wu J, Hernandez ML, and Peden DB: Effect of inhaled dust mite allergen on regional particle deposition and mucociliary clearance in allergic asthmatics. Clin Exp Allergy. 2011;41: 1719-1728.
40. Pirildar T, Gumuser G, Ruksen E, Sakar A, Dinc G, and Sayit E: Assessment of alveolar epithelial permeability with Tc-99m DTPA aerosol scintigraphy in patients with Sjogren syndrome. Rheumatol Int. 2010;30:599-604.
41. Tillie-Leblond I, Gosset P, Le Berre R, Janin A, Prangère T, Tonnel AB, and Guery BP: Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats. Eur Resp J. 2007;30:31-39.
42. Tossici-Bolt L, Fleming JS, Conway JH, and Martonen TB: Analytical technique to recover the third dimension in planar imaging of inhaled aerosols: (1) Impact on spatial quantification. J Aerosol Med. 2006;19:565-579.
43. Hashish A, Fleming J, Conway J, Halson P, Moore E, Williams TJ, Bailey AG, Nassim M, and Holgate ST: Lung deposition of particles by airway generation in healthy subjects: three-dimensional radionuclide imaging and numerical model prediction. J Aerosol Sci. 1998;29:205-215.
44. Fleming JS, Conway RJH, Holgate ST, Bailey AG, and Martonen TB: Comparison of methods for deriving aerosol deposition by airway generation from three-dimensional radionuclide imaging. J Aerosol Sci. 2000;31:1251-1259.
45. Fleming JS, Sauret V, Conway JH, and Martonen TB: Validation of the conceptual anatomical model of the lung airway. J Aerosol Med. 2004;17:260-269.
46. Montesantos S, Fleming JS, and Tossici-Bolt L: A spatial model of the human airway tree: the hybrid conceptual model. J Aerosol Med Pulm Drug Deliv. 2010;23:59-68.
47. Petersson J, Sánchez-Crespo A, Larsson SA, and Mure M: Physiological imaging of the lung: single-photon-emission computed tomography (SPECT). J Appl Physiol. 2007;102: 468-476.
48. Bajc M, and Jonson B: Ventilation/perfusion SPECT for diagnosis of pulmonary embolism and other diseases. Int J Mol Imaging. 2011;2011:682949.
49. Castro M, Fain SB, Hoffman EA, Gierada DS, Erzurum SC, and Wenzel S: Lung imaging in asthmatic patients: the picture is clearer. J Allergy Clin Immunol. 2011;128:467-478.
50. Tunon-de-Lara J-M, Laurent F, Giraud V, Perez T, Aguilaniu B, Meziane H, Basset-Merle A, and Chanez P: Air trapping in mild and moderate asthma: effect of inhaled corticosteroids. J Allergy Clin Immunol. 2007;119:583-590.
51. Busacker A, Newell JD, Keefe T, Hoffman EA, Granroth JC, Castro M, Fain S, and Wenzel S: A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest. 2009;135: 48-56.
52. International Commission on Radiological Protection: Radiation doses to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). ICRP Publication 80. Ann ICRP. 1998;28:1-126.
53. Administration of Radioactive Substance Advisory Committee: Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Health Protection Agency, 2011 revision. Available at: http://www.arsac.org.uk/notes-for-guidance/documents/ ARSACNFG2006Corrected2011. pdf. Accessed January 27, 2013.
54. Health Protection Agency: Understanding radiation. Available at: http://www.hpa.org.uk/Topics/Radiation/UnderstandingRadiation/ UnderstandingRadiationTopics/Medical Radiation/. Accessed January 27, 2013.
55. Rutgers SR, Timens W, Kauffman HF, and Postma DS: Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease. Clin Exp Allergy. 2001;31:193-205.
56. Thiberville L, Moreno-Swirc S, Vercauteren T, Peltier E, Cavé C, and Bourg Heckly G: In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy. Am J Respir Crit Care Med. 2007;175:22-31.
57. Soja J, Grzanka P, Sladek K, Okon K, Cmiel A, Mikos M, Mikrut S, Pulka G, Gross-Sondej I, Nizankowska-Mogilnicka E, and Szczeklik A: The use of endobronchial ultrasonography in assessment of bronchial wall remodeling in patients with asthma. Chest. 2009;136:797-804.
58. Coxson HO, Mayo J, Lam S, Santyr G, Parraga G, and Sin DD: New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:588-597.